GGrantIndex
Sort

40,608 grants matching prostate cancer

Mechanisms of Radioresistance and Cell Cycle Progression

$360,812
Howard B Lieberman · Columbia University Health Sciences · R01 · FY2009 · CA

Mechanisms of Radioresistance and Cell Cycle Progression

$360,812
Howard B Lieberman · Columbia University Health Sciences · R01 · FY2010 · CA

Mechanisms of Radioresistance and Cell Cycle Progression

$360,812
Howard B Lieberman · Columbia University Health Sciences · R01 · FY2007 · CA

Mechanisms of Radioresistance and Cell Cycle Progression

$360,812
Howard B Lieberman · Columbia University Health Sciences · R01 · FY2008 · CA

Gut bacterial metabolism of the side-chain of corticosteroids

$360,804
Jason Michael Ridlon · University Of Illinois At Urbana-Champaign · R01 · FY2023 · GM

HIFU and Immunotherapy Treatment of Metastatic Prostate Cancer

$360,640
Narendra T Sanghvi · Focus Surgery, Inc. · R44 · FY2008 · CA

Research Training in Neuro-Oncology

$360,612
Henry S. Friedman · Duke University · T32 · FY2012 · CA

Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening

$360,553
Kathryn L Terry · Brigham And Women'S Hospital · R01 · FY2019 · CA

PROMOTING HEALTH IN PROSTATE &BREAST CANCER

$360,530
Duke University · R01 · FY2004 · CA

Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC

$360,516
Myles A Brown · Beth Israel Deaconess Medical Center · P01 · FY2019 · CA

Effects of Radiation on Brain Microvasculature and Cognition

$360,494
William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · NS

Roles of SRC-3 in Development and Disease

$360,375
Jianming Xu · Baylor College Of Medicine · R01 · FY2009 · DK

GSTP1 Promoter Hypermethylation in Human Prostate Cancer

$360,375
William George Nelson · Johns Hopkins University · R01 · FY2010 · CA

GSTP1 Promoter Hypermethylation in Human Prostate Cancer

$360,375
William George Nelson · Johns Hopkins University · R01 · FY2009 · CA

NM MINORITY-BASED COMMUNITY CLINICAL ONC. PROGRAM

$360,374
University Of New Mexico · U10 · FY2002 · CA

A metabolic role for PML in tumor suppression

$360,359
Pier Paolo Pandolfi · Beth Israel Deaconess Medical Center · R01 · FY2010 · CA

Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit

$360,358
Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2010 · CA

Genomic and environmental drivers of HCC in Non-Hispanic Blacks: Nature and nurture

$360,350
Andrea D. Branch · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · CA

Proteases in Prostate Cancer Bone Metastasis

$360,340
Michael L Cher · Wayne State University · R01 · FY2006 · DK

Computational and Experimental Modeling of Alternative Polyadenylation

$360,307
Wei Li · University Of California-Irvine · R01 · FY2025 · CA

Hexim-1, a novel regulator of prostate cancer progression

$360,292
Manya Dhar-Mascareno · College At Old Westbury · R15 · FY2012 · CA

Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugs

$360,281
Xiumei Huang · Indiana University Indianapolis · R01 · FY2021 · CA

Reducing toxicity from prostate cancer radiotherapy through genetics and technology

$360,281
Amar U Kishan · University Of California Los Angeles · R37 · FY2025 · CA

Reducing toxicity from prostate cancer radiotherapy through genetics and technology

$360,281
Amar U Kishan · University Of California Los Angeles · R37 · FY2024 · CA

Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugs

$360,281
Xiumei Huang · Indiana University Indianapolis · R01 · FY2020 · CA